Evofem Biosciences Inc. (EVFM) OTC MARKETS

$0.48 (0.15) (-23.36%)

Market Cap: -

As of 08/10/22 04:00 PM EDT. Market closed.

(EVFM)

Evofem Biosciences Inc. (EVFM)
OTC MARKETS

$0.48
(0.15) (-23.36%)

Market Cap: -

As of 08/10/22 04:00 PM EDT. Market closed.

Add to Portfolio

evofem is a biotechnology company focusing on developing innovative reproductive health products for women in every global market. evofem develops and markets products that are woman-controlled, non-invasive and rapidly reversible. women need access to effective products that are well suited to their lifestyle and consistent with their core values. products include: amphora™ - a ... read more

evofem is a biotechnology company focusing on developing innovative reproductive health products for women in every global market. evofem develops and markets products that are woman-controlled, non-invasive and rapidly reversible. women need access to effective products that are well suited to their lifestyle and consistent with their core values. products include: amphora™ - a non-hormonal vaginal gel being investigated for contraceptive and microbicidal properties. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Saundra Pelletier
Full Time Employees
93
CEO Compensation (Base)
$738,375
CEO Compensation (Total)
$8.30M
URL
Address
12400 High Bluff Dr Ste 600, California, San Diego, 92130-3077.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Saundra Pelletier
Full Time Employees
93
CEO Compensation (Base)
$738,375
CEO Compensation (Total)
$8.30M
Address
12400 High Bluff Dr Ste 600, California, San Diego, 92130-3077.
PRICE CHART FOR EVOFEM BIOSCIENCES INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.45
Previous Close
$0.62
Days Range
$0.43 - $0.59
52 week range
- - -
Volume
83,216
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
45,939,509
Open
$0.45
Previous Close
$0.62
Days Range
$0.43 - $0.59
52 week range
- - -
Volume
83,216
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
45,939,509
FINANCIAL STATEMENTS FOR EVOFEM BIOSCIENCES INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR EVOFEM BIOSCIENCES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Zhang YanCFOJan 12, 2024 Sale$0.0410440Jan 12, 2024, 05:13 PM
Kamdar Kim P.DirectorDec 21, 2023 Sale$0.621060Dec 22, 2023, 04:05 PM
PELLETIER SAUNDRA LChief Executive OfficerMay 27, 2022 Buy$0.35141,00049,702236,722May 31, 2022, 08:55 AM
Fitzpatrick Alexander AGeneral Counsel and SecretaryDec 20, 2021 Buy$0.3925,0009,725336,422Dec 20, 2021, 04:20 PM
File Justin J.Chief Financial OfficerDec 20, 2021 Buy$0.3740,59415,020480,982Dec 20, 2021, 04:20 PM
PELLETIER SAUNDRA LChief Executive OfficerDec 20, 2021 Buy$0.38135,00050,625985,837Dec 20, 2021, 04:19 PM
Barrans RussellChief Commercial OfficerJul 08, 2021 Option Exercise$0.9819,99819,498448,554Jul 09, 2021, 04:02 PM
File Justin J.Chief Financial OfficerJun 10, 2021 Buy$1.0324,50025,235440,388Jun 10, 2021, 07:30 PM
PELLETIER SAUNDRA LChief Executive OfficerJun 10, 2021 Buy$1.0350,00051,500850,837Jun 10, 2021, 07:30 PM
Fitzpatrick Alexander AGeneral Counsel and SecretaryJun 10, 2021 Buy$1.0210,00010,250311,422Jun 10, 2021, 07:29 PM
File Justin J.Chief Financial OfficerMay 20, 2021 Option Exercise$0.8642,28036,361415,888May 21, 2021, 04:25 PM
PELLETIER SAUNDRA LChief Executive OfficerMay 20, 2021 Option Exercise$0.86105,30090,558800,837May 21, 2021, 04:25 PM
PELLETIER SAUNDRA LChief Executive OfficerMar 09, 2021 Buy$2.2845,249103,168906,137Mar 09, 2021, 06:59 PM
File Justin J.Chief Financial OfficerNov 17, 2020 Buy$2.177,76016,839258,168Nov 18, 2020, 05:22 PM
Fitzpatrick Alexander AGeneral Counsel and SecretaryNov 17, 2020 Buy$2.209,09019,998143,542Nov 18, 2020, 05:14 PM
Barrans RussellChief Commercial OfficerSep 11, 2020 Buy$2.083,0006,240279,052Sep 11, 2020, 05:20 PM
Barrans RussellChief Commercial OfficerSep 10, 2020 Buy$2.711,0002,710276,052Sep 11, 2020, 05:20 PM
PELLETIER SAUNDRA LChief Executive OfficerSep 08, 2020 Sale$3.26122,500399,350360,888Sep 10, 2020, 08:04 PM
Link Fund Solutions Ltd10% OwnerJun 04, 2020 Sale$0.239,138,5042,101,8560Jul 17, 2020, 11:11 AM
Barrans RussellChief Commercial OfficerJul 08, 2020 Option Exercise$3.3020,38167,257275,052Jul 09, 2020, 06:17 PM
Rarick Lisa DaleDirectorJun 17, 2020 Buy$2.995,25015,6985,250Jun 18, 2020, 04:29 PM
Hall William WalmsleyDirectorJun 15, 2020 Buy$2.855,00014,2505,000Jun 18, 2020, 04:29 PM
Hall William WalmsleyDirectorJun 15, 2020 Buy$2.855,00014,2505,000Jun 17, 2020, 08:38 PM
Kamdar Kim P.DirectorJun 12, 2020 Buy$2.945,00014,7009,287Jun 16, 2020, 04:35 PM
File Justin J.Chief Financial OfficerJun 12, 2020 Buy$3.148,50026,690250,408Jun 15, 2020, 04:16 PM
ACACIA RESEARCH CORP10% OwnerJun 04, 2020 Sale$3.219,138,50429,325,4601,000Jun 09, 2020, 09:08 PM
Invesco Ltd.10% OwnerMay 14, 2020 Option Exercise$5.1378,013400,20712,446,479Jun 09, 2020, 06:49 AM
Invesco Ltd.10% OwnerJun 05, 2020 Buy$3.50857,1433,000,00113,226,532Jun 09, 2020, 06:49 AM
Invesco Ltd.10% OwnerMay 26, 2020 Sale$5.7973,879427,77212,369,454Jun 09, 2020, 06:49 AM
Invesco Ltd.10% OwnerMay 15, 2020 Sale$5.043,21116,18312,443,268Jun 09, 2020, 06:49 AM
File Justin J.Chief Financial OfficerJun 05, 2020 Option Exercise$3.3142,810141,701237,605Jun 08, 2020, 05:43 PM
Culwell KellyChief Medical OfficerJun 05, 2020 Option Exercise$3.3131,548104,424115,451Jun 08, 2020, 05:43 PM
PELLETIER SAUNDRA LChief Executive OfficerJun 05, 2020 Option Exercise$3.3185,620283,402479,085Jun 08, 2020, 05:42 PM
Barrans RussellChief Commercial OfficerJun 05, 2020 Option Exercise$3.3115,45551,156293,509Jun 08, 2020, 05:42 PM
Fitzpatrick Alexander AGeneral Counsel and SecretaryJun 05, 2020 Option Exercise$3.3131,590104,563134,452Jun 08, 2020, 05:41 PM
PELLETIER SAUNDRA LChief Executive OfficerMay 22, 2020 Option Exercise$4.9984,525421,780564,705May 26, 2020, 05:17 PM
Fitzpatrick Alexander AGeneral Counsel and SecretaryMay 22, 2020 Option Exercise$4.9939,487197,040166,042May 26, 2020, 05:16 PM
Culwell KellyChief Medical OfficerMay 22, 2020 Option Exercise$4.9939,435196,781146,999May 26, 2020, 05:16 PM
Barrans RussellChief Commercial OfficerMay 22, 2020 Option Exercise$4.9919,47497,175308,964May 26, 2020, 05:16 PM
File Justin J.Chief Financial OfficerMay 22, 2020 Option Exercise$4.9942,262210,887280,415May 26, 2020, 05:15 PM
Barrans RussellChief Commercial OfficerMay 06, 2020 Option Exercise$5.243,80219,922328,438May 08, 2020, 12:32 PM
Culwell KellyChief Medical OfficerMay 06, 2020 Option Exercise$5.247,79240,830186,434May 08, 2020, 12:31 PM
File Justin J.Chief Financial OfficerMay 06, 2020 Option Exercise$5.248,42044,121322,677May 08, 2020, 12:31 PM
PELLETIER SAUNDRA LChief Executive OfficerMay 06, 2020 Option Exercise$5.2416,90588,582649,230May 08, 2020, 12:31 PM
Fitzpatrick Alexander AGeneral Counsel and SecretaryMay 06, 2020 Option Exercise$5.247,80240,882205,529May 08, 2020, 12:30 PM
Culwell KellyChief Medical OfficerMay 01, 2020 Sale$4.751,0004,750194,226May 01, 2020, 08:12 PM
Culwell KellyChief Medical OfficerApr 30, 2020 Sale$4.661,0004,660195,226May 01, 2020, 08:12 PM
Culwell KellyChief Medical OfficerFeb 19, 2020 Sale$7.001,0007,000196,226Feb 21, 2020, 02:10 PM
Barrans RussellChief Commercial OfficerFeb 19, 2020 Sale$6.5014,95797,221332,240Feb 21, 2020, 02:10 PM
Barrans RussellChief Commercial OfficerFeb 05, 2020 Option Exercise$5.218994,684197,197Feb 07, 2020, 04:33 PM
PELLETIER SAUNDRA LChief Executive OfficerFeb 05, 2020 Option Exercise$5.213,84620,038366,135Feb 07, 2020, 04:33 PM
File Justin J.Chief Financial OfficerFeb 05, 2020 Option Exercise$5.213,84620,038181,097Feb 07, 2020, 04:32 PM
Culwell KellyChief Medical OfficerFeb 05, 2020 Option Exercise$5.213,68819,21447,226Feb 07, 2020, 04:32 PM
Barrans RussellChief Commercial OfficerJan 16, 2020 Sale$6.501,57810,257196,298Jan 21, 2020, 01:13 PM
File Justin J.Chief Financial OfficerJan 13, 2020 Sale$6.001,6489,888177,251Jan 15, 2020, 04:22 PM
PELLETIER SAUNDRA LChief Executive OfficerJan 13, 2020 Sale$6.003,29519,770362,289Jan 15, 2020, 04:22 PM
PELLETIER SAUNDRA LChief Executive OfficerJan 02, 2020 Sale$6.056,70540,565365,584Jan 06, 2020, 03:08 PM
File Justin J.Chief Financial OfficerJan 02, 2020 Sale$6.053,35220,280178,899Jan 06, 2020, 03:07 PM
Culwell KellyChief Medical OfficerDec 02, 2019 Sale$7.351,0007,35043,538Dec 04, 2019, 05:34 PM
File Justin J.Chief Financial OfficerDec 02, 2019 Sale$7.1610,00071,600182,251Dec 04, 2019, 05:33 PM
PELLETIER SAUNDRA LChief Executive OfficerDec 02, 2019 Sale$7.3020,000146,000372,289Dec 04, 2019, 05:33 PM
PELLETIER SAUNDRA LChief Executive OfficerNov 25, 2019 Option Exercise$6.2222,387139,247392,289Nov 26, 2019, 05:15 PM
Barrans RussellChief Commercial OfficerNov 25, 2019 Option Exercise$6.229,27757,703197,876Nov 26, 2019, 05:15 PM
Fitzpatrick Alexander AGeneral Counsel and SecretaryNov 25, 2019 Option Exercise$6.227,74748,18663,331Nov 26, 2019, 05:15 PM
Culwell KellyChief Medical OfficerNov 25, 2019 Option Exercise$6.225,18732,26344,538Nov 26, 2019, 05:14 PM
File Justin J.Chief Financial OfficerNov 25, 2019 Option Exercise$6.2210,10262,834192,251Nov 26, 2019, 05:14 PM
Barrans RussellChief Commercial OfficerNov 20, 2019 Option Exercise$5.749,04451,913207,153Nov 21, 2019, 08:19 PM
Culwell KellyChief Medical OfficerNov 20, 2019 Option Exercise$5.745,18729,77349,725Nov 21, 2019, 08:18 PM
PELLETIER SAUNDRA LChief Executive OfficerNov 20, 2019 Option Exercise$5.7422,657130,051424,676Nov 21, 2019, 08:18 PM
PELLETIER SAUNDRA LChief Executive OfficerNov 21, 2019 Sale$6.0110,00060,100414,676Nov 21, 2019, 08:18 PM
File Justin J.Chief Financial OfficerNov 20, 2019 Option Exercise$5.7410,10257,985207,353Nov 21, 2019, 08:18 PM
File Justin J.Chief Financial OfficerNov 21, 2019 Sale$6.004,90029,400202,353Nov 21, 2019, 08:18 PM
File Justin J.Chief Financial OfficerNov 20, 2019 Sale$6.00100600207,253Nov 21, 2019, 08:18 PM
Fitzpatrick Alexander AGeneral Counsel and SecretaryNov 20, 2019 Option Exercise$5.747,74744,46871,078Nov 21, 2019, 08:17 PM
Fitzpatrick Alexander AGeneral Counsel and SecretaryOct 16, 2019 Option Exercise$5.0118,42792,31978,825Oct 17, 2019, 02:15 PM
PELLETIER SAUNDRA LChief Executive OfficerAug 22, 2019 Option Exercise$5.134,92325,255447,333Aug 26, 2019, 06:37 PM
Barrans RussellChief Commercial OfficerAug 22, 2019 Option Exercise$5.139624,935216,197Aug 26, 2019, 06:37 PM
Culwell KellyChief Medical OfficerAug 22, 2019 Option Exercise$5.138644,43254,912Aug 26, 2019, 06:36 PM
Fitzpatrick Alexander AGeneral Counsel and SecretaryAug 22, 2019 Option Exercise$5.131,2966,64897,252Aug 26, 2019, 06:36 PM
File Justin J.Chief Financial OfficerAug 22, 2019 Option Exercise$5.131,5587,993217,455Aug 26, 2019, 06:36 PM
Barrans RussellChief Commercial OfficerJul 08, 2019 Option Exercise$4.9913,25766,152217,159Jul 10, 2019, 07:06 PM
Barrans RussellChief Commercial OfficerJun 10, 2019 Option Exercise$6.365,96537,93780,416Jun 12, 2019, 04:39 PM
Culwell KellyChief Medical OfficerJun 10, 2019 Option Exercise$6.365,18732,98955,776Jun 12, 2019, 04:39 PM
File Justin J.Chief Financial OfficerJun 10, 2019 Option Exercise$6.3610,18564,777219,013Jun 12, 2019, 04:39 PM
PELLETIER SAUNDRA LChief Executive OfficerJun 10, 2019 Option Exercise$6.3635,826227,853452,256Jun 12, 2019, 04:38 PM
Fitzpatrick Alexander AGeneral Counsel and SecretaryJun 10, 2019 Option Exercise$6.367,77749,46298,548Jun 12, 2019, 04:38 PM
Invesco Ltd.10% OwnerJun 10, 2019 Buy$4.502,222,2229,999,99911,812,910Jun 12, 2019, 10:41 AM
PDL BIOPHARMA, INC.10% OwnerJun 10, 2019 Buy$4.506,666,66730,000,00213,333,334Jun 10, 2019, 06:16 PM
Kamdar Kim P.DirectorMay 21, 2019 Sale$5.076553,3210May 23, 2019, 04:29 PM
File Justin J.Chief Financial OfficerApr 01, 2019 Option Exercise$3.551,2924,587229,198Apr 03, 2019, 06:43 PM
Fitzpatrick Alexander AGeneral Counsel and SecretaryApr 01, 2019 Option Exercise$3.551,2984,608106,325Apr 03, 2019, 06:42 PM
Culwell KellyChief Medical OfficerApr 01, 2019 Option Exercise$3.551,0223,62860,963Apr 03, 2019, 06:41 PM
Barrans RussellChief Commercial OfficerApr 01, 2019 Option Exercise$3.551,1604,11886,381Apr 03, 2019, 06:40 PM
PELLETIER SAUNDRA LChief Executive OfficerApr 01, 2019 Option Exercise$3.553,73113,245488,082Apr 03, 2019, 06:39 PM
Invesco Ltd.10% OwnerFeb 08, 2019 Buy$2.64425,5311,123,4029,590,688Feb 12, 2019, 04:05 PM
Barrans RussellChief Commercial OfficerNov 21, 2018 Buy$3.5527999012,820Nov 26, 2018, 03:07 PM
Fitzpatrick Alexander AGeneral Counsel and SecretaryOct 16, 2018 Option Exercise$3.7817,37765,68557,623Oct 17, 2018, 12:43 PM
Fitzpatrick Alexander AGeneral Counsel and SecretaryAug 21, 2018 Buy$2.275001,13575,000Aug 21, 2018, 04:06 PM
Fitzpatrick Alexander AGeneral Counsel and SecretaryAug 20, 2018 Buy$2.204,5009,90074,500Aug 21, 2018, 04:06 PM
Culwell KellyChief Medical OfficerAug 16, 2018 Buy$2.243,0006,72011,985Aug 20, 2018, 06:25 PM
Lynch Thomas GDirectorAug 14, 2018 Buy$2.1031,07165,249106,071Aug 15, 2018, 07:09 PM
Lynch Thomas GDirectorAug 15, 2018 Buy$2.3368,929160,605175,000Aug 15, 2018, 07:09 PM
Barrans RussellChief Commercial OfficerAug 10, 2018 Buy$1.983,7157,35612,541Aug 13, 2018, 06:50 PM
PELLETIER SAUNDRA LChief Executive OfficerAug 10, 2018 Buy$2.1110,00021,100341,813Aug 13, 2018, 06:48 PM
Barrans RussellChief Commercial OfficerJul 02, 2018 Option Exercise$2.462,8406,9868,826Jul 03, 2018, 05:03 PM
File Justin J.Chief Financial OfficerJul 02, 2018 Option Exercise$2.46119,510293,995180,490Jul 03, 2018, 04:59 PM
PELLETIER SAUNDRA LChief Executive OfficerJul 02, 2018 Option Exercise$2.46493,1871,213,240331,813Jul 03, 2018, 04:58 PM
Culwell KellyChief Medical OfficerJul 02, 2018 Option Exercise$2.464,74811,6808,985Jul 03, 2018, 04:54 PM
Invesco Ltd.10% OwnerMay 22, 2018 Buy$4.692,127,6599,978,7219,165,157May 24, 2018, 03:32 PM
DEMSKI MARTHA JDirectorJun 21, 2016 Option Exercise$1.1316,39318,52416,393Jun 23, 2016, 06:58 PM
Alta Partners VIII, L.P.Former 10% OwnerDec 30, 2015 Sale$1.44250,000360,0001,339,776Dec 30, 2015, 05:18 PM
Alta Partners VIII, L.P.Former 10% OwnerDec 29, 2015 Sale$1.53493,654755,2911,589,776Dec 30, 2015, 05:18 PM
Alta Partners VIII, L.P.Former 10% OwnerDec 28, 2015 Sale$1.5954,33386,3892,083,430Dec 30, 2015, 05:18 PM
Locke Kenneth WChief Scientific OfficerDec 17, 2015 Sale$1.265987530Dec 21, 2015, 05:02 PM
Knudson Susan A.Chief Financial OfficerDec 17, 2015 Sale$1.261,0051,2660Dec 21, 2015, 04:55 PM
Alta Partners VIII, L.P.10% OwnerDec 15, 2015 Sale$1.44529,261762,1362,137,763Dec 17, 2015, 05:00 PM
Locke Kenneth WChief Scientific OfficerNov 18, 2015 Option Exercise$8.306,09850,6196,391Nov 19, 2015, 07:31 PM
Locke Kenneth WChief Scientific OfficerNov 18, 2015 Sale$8.306,09850,619293Nov 19, 2015, 07:31 PM
Mahaffey George WPresident and CEOOct 15, 2015 Option Exercise$8.6026,681229,457171,040Oct 19, 2015, 06:27 PM
Kemmerer ChristopherVP, Pharma Dev & ManufacturingSep 18, 2015 Option Exercise$1.341,0001,34211,848Sep 22, 2015, 04:36 PM
Kemmerer ChristopherVP, Pharma Dev & ManufacturingSep 18, 2015 Sale$12.191,00012,19510,848Sep 22, 2015, 04:36 PM
Knudson Susan A.Chief Financial OfficerSep 01, 2015 Option Exercise$1.223,0003,6603,492Sep 03, 2015, 05:14 PM
Knudson Susan A.Chief Financial OfficerSep 01, 2015 Sale$11.333,00033,990492Sep 03, 2015, 05:14 PM
Kemmerer ChristopherVP, Pharma Dev & ManufacturingAug 07, 2015 Option Exercise$1.341,0001,34211,848Aug 17, 2015, 06:50 PM
Kemmerer ChristopherVP, Pharma Dev & ManufacturingAug 07, 2015 Option Exercise$1.221,0001,22011,848Aug 10, 2015, 07:44 PM
Kemmerer ChristopherVP, Pharma Dev & ManufacturingAug 07, 2015 Sale$12.881,00012,88010,848Aug 10, 2015, 07:44 PM
Kemmerer ChristopherVP, Pharma Dev & ManufacturingJun 12, 2015 Option Exercise$1.2210,84813,23510,848Jun 16, 2015, 05:26 PM
Mahaffey George WPresident and CEOMar 19, 2015 Buy$7.761,0007,757197,721Mar 20, 2015, 07:38 PM
DP VII ASSOCIATES LP10% OwnerNov 25, 2014 Option Exercise$14.002,68337,56248,025Dec 10, 2014, 04:17 PM
DP VII ASSOCIATES LP10% OwnerNov 25, 2014 Option Exercise$8.544,39737,55049,750Dec 10, 2014, 04:17 PM
DOMAIN PARTERS VII L P10% OwnerNov 25, 2014 Option Exercise$14.00157,3172,202,4383,021,643Dec 10, 2014, 04:09 PM
DOMAIN PARTERS VII L P10% OwnerNov 25, 2014 Option Exercise$8.54257,8952,202,4233,122,775Dec 10, 2014, 04:09 PM
DOMAIN PARTERS VII L P10% OwnerNov 25, 2014 Buy$14.0070,000980,0003,091,643Dec 10, 2014, 04:09 PM
JANNEY DANIELDirectorNov 25, 2014 Option Exercise$8.5493,676799,9932,595,257Dec 01, 2014, 04:52 PM
DP VII ASSOCIATES LP10% OwnerNov 25, 2014 Option Exercise$14.002,68337,56248,023Nov 26, 2014, 11:10 AM
DP VII ASSOCIATES LP10% OwnerNov 25, 2014 Option Exercise$8.544,39737,55049,748Nov 26, 2014, 11:10 AM
DOMAIN PARTERS VII L P10% OwnerNov 25, 2014 Option Exercise$14.00157,3172,202,4383,021,642Nov 26, 2014, 11:06 AM
DOMAIN PARTERS VII L P10% OwnerNov 25, 2014 Option Exercise$8.54257,8952,202,4233,122,774Nov 26, 2014, 11:06 AM
DOMAIN PARTERS VII L P10% OwnerNov 25, 2014 Buy$14.0070,000980,0003,091,642Nov 26, 2014, 11:06 AM
RMI Investments S.a.r.l.10% OwnerNov 25, 2014 Buy$14.0070,000980,0001,585,549Nov 25, 2014, 07:16 PM
Gorbachev MaximDirectorNov 25, 2014 Buy$14.0070,000980,0001,585,549Nov 25, 2014, 07:11 PM
JANNEY DANIELDirectorNov 25, 2014 Buy$14.0070,000980,0002,667,024Nov 25, 2014, 07:09 PM
JANNEY DANIELDirectorNov 25, 2014 Sale$14.00149,2862,090,0042,597,024Nov 25, 2014, 07:09 PM
JANNEY DANIELDirectorNov 25, 2014 Option Exercise$9.59244,7292,347,5952,654,039Nov 25, 2014, 07:09 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Zhang YanCFO01/12/20244
Kamdar Kim P.Director12/21/20236
PELLETIER SAUNDRA LChief Executive Officer05/27/202249,702
Fitzpatrick Alexander AGeneral Counsel and Secretary12/20/20219,725
File Justin J.Chief Financial Officer12/20/202115,020
PELLETIER SAUNDRA LChief Executive Officer12/20/202150,625
Barrans RussellChief Commercial Officer07/08/202119,498
File Justin J.Chief Financial Officer06/10/202125,235
PELLETIER SAUNDRA LChief Executive Officer06/10/202151,500
Fitzpatrick Alexander AGeneral Counsel and Secretary06/10/202110,250
File Justin J.Chief Financial Officer05/20/202136,361
PELLETIER SAUNDRA LChief Executive Officer05/20/202190,558
PELLETIER SAUNDRA LChief Executive Officer03/09/2021103,168
File Justin J.Chief Financial Officer11/17/202016,839
Fitzpatrick Alexander AGeneral Counsel and Secretary11/17/202019,998
Barrans RussellChief Commercial Officer09/11/20206,240
Barrans RussellChief Commercial Officer09/10/20202,710
PELLETIER SAUNDRA LChief Executive Officer09/08/2020399,350
Link Fund Solutions Ltd10% Owner06/04/20202,101,856
Barrans RussellChief Commercial Officer07/08/202067,257
Rarick Lisa DaleDirector06/17/202015,698
Hall William WalmsleyDirector06/15/202014,250
Hall William WalmsleyDirector06/15/202014,250
Kamdar Kim P.Director06/12/202014,700
File Justin J.Chief Financial Officer06/12/202026,690
ACACIA RESEARCH CORP10% Owner06/04/202029,325,460
Invesco Ltd.10% Owner05/14/2020400,207
Invesco Ltd.10% Owner06/05/20203,000,001
Invesco Ltd.10% Owner05/26/2020427,772
Invesco Ltd.10% Owner05/15/202016,183
File Justin J.Chief Financial Officer06/05/2020141,701
Culwell KellyChief Medical Officer06/05/2020104,424
PELLETIER SAUNDRA LChief Executive Officer06/05/2020283,402
Barrans RussellChief Commercial Officer06/05/202051,156
Fitzpatrick Alexander AGeneral Counsel and Secretary06/05/2020104,563
PELLETIER SAUNDRA LChief Executive Officer05/22/2020421,780
Fitzpatrick Alexander AGeneral Counsel and Secretary05/22/2020197,040
Culwell KellyChief Medical Officer05/22/2020196,781
Barrans RussellChief Commercial Officer05/22/202097,175
File Justin J.Chief Financial Officer05/22/2020210,887
Barrans RussellChief Commercial Officer05/06/202019,922
Culwell KellyChief Medical Officer05/06/202040,830
File Justin J.Chief Financial Officer05/06/202044,121
PELLETIER SAUNDRA LChief Executive Officer05/06/202088,582
Fitzpatrick Alexander AGeneral Counsel and Secretary05/06/202040,882
Culwell KellyChief Medical Officer05/01/20204,750
Culwell KellyChief Medical Officer04/30/20204,660
Culwell KellyChief Medical Officer02/19/20207,000
Barrans RussellChief Commercial Officer02/19/202097,221
Barrans RussellChief Commercial Officer02/05/20204,684
PELLETIER SAUNDRA LChief Executive Officer02/05/202020,038
File Justin J.Chief Financial Officer02/05/202020,038
Culwell KellyChief Medical Officer02/05/202019,214
Barrans RussellChief Commercial Officer01/16/202010,257
File Justin J.Chief Financial Officer01/13/20209,888
PELLETIER SAUNDRA LChief Executive Officer01/13/202019,770
PELLETIER SAUNDRA LChief Executive Officer01/02/202040,565
File Justin J.Chief Financial Officer01/02/202020,280
Culwell KellyChief Medical Officer12/02/20197,350
File Justin J.Chief Financial Officer12/02/201971,600
PELLETIER SAUNDRA LChief Executive Officer12/02/2019146,000
PELLETIER SAUNDRA LChief Executive Officer11/25/2019139,247
Barrans RussellChief Commercial Officer11/25/201957,703
Fitzpatrick Alexander AGeneral Counsel and Secretary11/25/201948,186
Culwell KellyChief Medical Officer11/25/201932,263
File Justin J.Chief Financial Officer11/25/201962,834
Barrans RussellChief Commercial Officer11/20/201951,913
Culwell KellyChief Medical Officer11/20/201929,773
PELLETIER SAUNDRA LChief Executive Officer11/20/2019130,051
PELLETIER SAUNDRA LChief Executive Officer11/21/201960,100
File Justin J.Chief Financial Officer11/20/201957,985
File Justin J.Chief Financial Officer11/21/201929,400
File Justin J.Chief Financial Officer11/20/2019600
Fitzpatrick Alexander AGeneral Counsel and Secretary11/20/201944,468
Fitzpatrick Alexander AGeneral Counsel and Secretary10/16/201992,319
PELLETIER SAUNDRA LChief Executive Officer08/22/201925,255
Barrans RussellChief Commercial Officer08/22/20194,935
Culwell KellyChief Medical Officer08/22/20194,432
Fitzpatrick Alexander AGeneral Counsel and Secretary08/22/20196,648
File Justin J.Chief Financial Officer08/22/20197,993
Barrans RussellChief Commercial Officer07/08/201966,152
Barrans RussellChief Commercial Officer06/10/201937,937
Culwell KellyChief Medical Officer06/10/201932,989
File Justin J.Chief Financial Officer06/10/201964,777
PELLETIER SAUNDRA LChief Executive Officer06/10/2019227,853
Fitzpatrick Alexander AGeneral Counsel and Secretary06/10/201949,462
Invesco Ltd.10% Owner06/10/20199,999,999
PDL BIOPHARMA, INC.10% Owner06/10/201930,000,002
Kamdar Kim P.Director05/21/20193,321
File Justin J.Chief Financial Officer04/01/20194,587
Fitzpatrick Alexander AGeneral Counsel and Secretary04/01/20194,608
Culwell KellyChief Medical Officer04/01/20193,628
Barrans RussellChief Commercial Officer04/01/20194,118
PELLETIER SAUNDRA LChief Executive Officer04/01/201913,245
Invesco Ltd.10% Owner02/08/20191,123,402
Barrans RussellChief Commercial Officer11/21/2018990
Fitzpatrick Alexander AGeneral Counsel and Secretary10/16/201865,685
Fitzpatrick Alexander AGeneral Counsel and Secretary08/21/20181,135
Fitzpatrick Alexander AGeneral Counsel and Secretary08/20/20189,900
Culwell KellyChief Medical Officer08/16/20186,720
Lynch Thomas GDirector08/14/201865,249
Lynch Thomas GDirector08/15/2018160,605
Barrans RussellChief Commercial Officer08/10/20187,356
PELLETIER SAUNDRA LChief Executive Officer08/10/201821,100
Barrans RussellChief Commercial Officer07/02/20186,986
File Justin J.Chief Financial Officer07/02/2018293,995
PELLETIER SAUNDRA LChief Executive Officer07/02/20181,213,240
Culwell KellyChief Medical Officer07/02/201811,680
Invesco Ltd.10% Owner05/22/20189,978,721
DEMSKI MARTHA JDirector06/21/201618,524
Alta Partners VIII, L.P.Former 10% Owner12/30/2015360,000
Alta Partners VIII, L.P.Former 10% Owner12/29/2015755,291
Alta Partners VIII, L.P.Former 10% Owner12/28/201586,389
Locke Kenneth WChief Scientific Officer12/17/2015753
Knudson Susan A.Chief Financial Officer12/17/20151,266
Alta Partners VIII, L.P.10% Owner12/15/2015762,136
Locke Kenneth WChief Scientific Officer11/18/201550,619
Locke Kenneth WChief Scientific Officer11/18/201550,619
Mahaffey George WPresident and CEO10/15/2015229,457
Kemmerer ChristopherVP, Pharma Dev & Manufacturing09/18/20151,342
Kemmerer ChristopherVP, Pharma Dev & Manufacturing09/18/201512,195
Knudson Susan A.Chief Financial Officer09/01/20153,660
Knudson Susan A.Chief Financial Officer09/01/201533,990
Kemmerer ChristopherVP, Pharma Dev & Manufacturing08/07/20151,342
Kemmerer ChristopherVP, Pharma Dev & Manufacturing08/07/20151,220
Kemmerer ChristopherVP, Pharma Dev & Manufacturing08/07/201512,880
Kemmerer ChristopherVP, Pharma Dev & Manufacturing06/12/201513,235
Mahaffey George WPresident and CEO03/19/20157,757
DP VII ASSOCIATES LP10% Owner11/25/201437,562
DP VII ASSOCIATES LP10% Owner11/25/201437,550
DOMAIN PARTERS VII L P10% Owner11/25/20142,202,438
DOMAIN PARTERS VII L P10% Owner11/25/20142,202,423
DOMAIN PARTERS VII L P10% Owner11/25/2014980,000
JANNEY DANIELDirector11/25/2014799,993
DP VII ASSOCIATES LP10% Owner11/25/201437,562
DP VII ASSOCIATES LP10% Owner11/25/201437,550
DOMAIN PARTERS VII L P10% Owner11/25/20142,202,438
DOMAIN PARTERS VII L P10% Owner11/25/20142,202,423
DOMAIN PARTERS VII L P10% Owner11/25/2014980,000
RMI Investments S.a.r.l.10% Owner11/25/2014980,000
Gorbachev MaximDirector11/25/2014980,000
JANNEY DANIELDirector11/25/2014980,000
JANNEY DANIELDirector11/25/20142,090,004
JANNEY DANIELDirector11/25/20142,347,595
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR EVOFEM BIOSCIENCES INC
LOADING...